KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Divestments (2017 - 2025)

Historic Divestments for Bausch Health Companies (BHC) over the last 9 years, with Q3 2025 value amounting to $7.0 million.

  • Bausch Health Companies' Divestments rose 4000.0% to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $7.0 million for FY2024, which is 4000.0% up from last year.
  • According to the latest figures from Q3 2025, Bausch Health Companies' Divestments is $7.0 million, which was up 4000.0% from $5.0 million recorded in Q3 2024.
  • In the past 5 years, Bausch Health Companies' Divestments ranged from a high of $644.0 million in Q3 2021 and a low of $1.0 million during Q2 2023
  • Moreover, its 5-year median value for Divestments was $4.5 million (2021), whereas its average is $69.3 million.
  • Per our database at Business Quant, Bausch Health Companies' Divestments plummeted by 8095.24% in 2021 and then soared by 4000.0% in 2025.
  • Over the past 5 years, Bausch Health Companies' Divestments (Quarter) stood at $644.0 million in 2021, then crashed by 99.22% to $5.0 million in 2022, then dropped by 20.0% to $4.0 million in 2023, then increased by 25.0% to $5.0 million in 2024, then surged by 40.0% to $7.0 million in 2025.
  • Its last three reported values are $7.0 million in Q3 2025, $5.0 million for Q3 2024, and $1.0 million during Q2 2024.